HOLX vs SRPT · P/E 32, rev $4.10B vs rev $1.13B
Hologic Inc (HOLX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the HOLX and SRPT stock pages for the full models.
Not investment advice.